Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms

Blood. 2022 Apr 28;139(17):2716-2720. doi: 10.1182/blood.2021014890.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoantibodies
  • Humans
  • Interferon Type I*
  • Myeloproliferative Disorders*
  • Neoplasms*

Substances

  • Autoantibodies
  • Interferon Type I